28049-64-1

Basic information

• Product Name: 1-(2,6-dichlorophenyl)cyclobutane-1-carbonitrile
• Synonyms: 1-(2,6-dichlorophenyl)cyclobutane-1-carbonitrile
• CAS NO: 28049-64-1
• Molecular Weight: 226.105
• Mol File: 28049-64-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-(2,6-dichlorophenyl)cyclobutane-1-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2,6-dichlorophenyl)cyclobutane-1-carbonitrile(28049-64-1)
• EPA Substance Registry System: 1-(2,6-dichlorophenyl)cyclobutane-1-carbonitrile(28049-64-1)

Safety Data

• Hazardous Substances Data: 28049-64-1(Hazardous Substances Data)

Usage

General Description

1-(2,6-dichlorophenyl)cyclobutane-1-carbonitrile is a chemical compound that belongs to the class of cyclobutane derivatives. It is a white solid with the molecular formula C11H7Cl2N and a molar mass of 223.09 g/mol. 1-(2,6-dichlorophenyl)cyclobutane-1-carbonitrile is used in the synthesis of various pharmaceuticals and agrochemicals due to its potential as a building block in organic chemistry. It is also known for its use in the development of new materials and as a reagent in chemical research. However, it is important to handle this compound with care as it may be hazardous if not used properly and should only be handled by trained professionals in a controlled laboratory environment.

Upstream product

• 3215-64-3 2,6-dichlorophenylacetonitrile 
• 109-64-8 1,3-dibromo-propane 

Downstream Products

• 1039951-74-0 C₁₁H₁₀Cl₂O₂ 

Relevant articles and documents

Oxadiazole Amine Derivative Compounds as Histone Deacetylase 6 Inhibitor, and the Pharmaceutical Composition Comprising the same

The present invention relates to a novel compound having an activity of inhibiting histone deacetylase 6 (HDAC6), an optical isomer thereof or a pharmaceutically acceptable salt thereof, a use thereof for preparation of a drug for treatment, a pharmaceutical composition comprising the same, a treatment method using the composition, and a method for preparing the same. The novel compound, an optical isomer thereof or a pharmaceutically acceptable salt thereof according to the present invention has an activity of inhibiting histone deacetylase 6 (HDAC6), and is effective for preventing or treating HDAC6-related diseases, including infectious diseases; neoplasm; endocrine, nutritional and metabolic diseases; mental and behavior disorders; nerve disorders; eye and adnexa diseases; cardiovascular diseases; respiratory diseases; digestive organ diseases; skin and subcutaneous tissue diseases; musculoskeletal and connective tissue diseases; or congenital malformation, deformation and chromosomal abnormality.COPYRIGHT KIPO 2017